BPG致力于知识发现和传播
预出版
2021/6/21 3:49:13 | Browse: 166 | 下载: 227
Publication Name 世界华人消化杂志
手稿编号 38340
手稿来源省、自治区或特别行政区 天津市
专业类型 消化肿瘤学
手稿栏目类型 临床研究
文章标题 基于生物信息学分析PDE2A基因在消化系统肿瘤预后及免疫浸润的临床意义
手稿来源 自由来稿
所有作者列表 张钊熊, 韩强, 刘树业
基金项目及其编号
基金项目名称 基金编号
National Natural Science Foundation of China 81902986
通讯作者 刘树业, 博士, 主任技师, 300170, 天津市河东区津塘路83号, 天津市第三中心医院, 天津市人工细胞重点实验室, 卫生部人工细胞工程技术研究中心检验科. lshye@163.com
关键词 消化系统肿瘤; 免疫浸润; 预后; PDE2A; 生物信息学
核心内容提要 PDE2A表达与消化系统肿瘤免疫浸润有关. PDE2A高表达的肝癌和胰腺癌患者预后良好. PDE2A基因可能为潜在的消化系统肿瘤免疫治疗靶点和预后标志物.
引文著录 张钊熊, 韩强, 刘树业. 基于生物信息学分析PDE2A基因在消化系统肿瘤预后及免疫浸润的临床意义. 世界华人消化杂志 2021; 29(18): 1055-1063
Received
2021-05-11 07:20
Peer-Review Started
2021-05-11 08:17
To Make the First Decision
Return for Revision
2021-06-05 18:07
修回稿
2021-06-07 13:30
Second Decision
2021-06-18 10:42
期刊总编辑接受
公司总编辑接受
2021-06-21 03:49
预出版
2021-06-21 03:49
缴纳版面费
Edit the Manuscript by Language Editor
排版
2021-09-26 01:48
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 张砚梁
Science Editor 刘继红
评议人编号 03737320, 03656365, and 03656580
Editorial Director
Journal Chief Editor
Company Chief Editor 马俐
Language Editor
Production Editor 张砚梁
Responsible Production Editor 张砚梁
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma